All studies
Endocrinology · Claims · US
Ray 2026
Type 2 diabetes
ITTSuperiorityAcademia2/5 disclosures
Comparisons
3
In the analysis
3
all comparisons pooled
Target trials
1
Emulations reported
3
2 treatments
Design and methods
- Estimand
- ITT
- Design hypothesis
- Superiority
- Matching / weighting
- Matching weights
- Analysis method
- Weighted Cox proportional hazards model
- Missing data
- Complete case
- Covariates adjusted
- 87
- DAG
- No
- QBA
- No
Data and sample
- Data type
- Claims
- Data sources
- 1
- Geography
- US
- Eligible sample
- 8092
- Treated
- GLP-1RA 2006; DPP-4i 2006
- Control
- SU 2015
- Emulations
- 3
- Treatments compared
- 2
Transparency
- Protocol
- No pre-registration
- Preprint
- No preprint
- Data availability
- Unavailable
- Code availability
- Unavailable
- Conflicts of interest
- Declared: None
- Funding
- Declared: Public
- Funders
- Grant DB-2020C2-20326 and public research support
The 0-5 count records which disclosures are present. It is not a quality score: a data link does not establish that the data are reusable.
Provenance
- Review key
- 2026_Ray_GRADE
- DOI
- 10.1007/s11606-026-10170-7
- Affiliations
- University of Maryland and collaborating US academic institutions
- Sector
- Academia
- Target trials (study level)
- GRADE
- Registration
- NCT01794143